Stock Analysis

Polygiene Group Full Year 2024 Earnings: EPS: kr0.46 (vs kr8.31 loss in FY 2023)

OM:POLYG
Source: Shutterstock

Polygiene Group (STO:POLYG) Full Year 2024 Results

Key Financial Results

  • Revenue: kr156.9m (up 38% from FY 2023).
  • Net income: kr16.8m (up from kr303.6m loss in FY 2023).
  • Profit margin: 11% (up from net loss in FY 2023).
  • EPS: kr0.46 (up from kr8.31 loss in FY 2023).
revenue-and-expenses-breakdown
OM:POLYG Revenue and Expenses Breakdown February 18th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Polygiene Group Earnings Insights

The primary driver behind last 12 months revenue was the Polygiene segment contributing a total revenue of kr98.7m (63% of total revenue). The largest operating expense was General & Administrative costs, amounting to kr85.1m (94% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of kr3.68m. Explore how POLYG's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Chemicals industry in Sweden.

Performance of the Swedish Chemicals industry.

The company's shares are down 4.0% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Polygiene Group.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OM:POLYG

Polygiene Group

Provides antimicrobial solutions for textiles and other hard surfaces in the Asia Pacific, Europe, the Middle East, Africa, the United States, and internationally.

Flawless balance sheet and slightly overvalued.